The BioEE group and Dr. Doug Conrad were awarded a grant to develop a smartphone-based biosensor to monitor pH and pulmonary exacerbation biomarkers in patients with cystic fibrosis (CF). Read more here.
The BioEE group and Dr. Doug Conrad were awarded a grant to develop a smartphone-based biosensor to monitor pH and pulmonary exacerbation biomarkers in patients with cystic fibrosis (CF). Read more here.